Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
Genomics02:02

Genomics

39.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-trajectory patterns of ADL, cognition, and depression with fall risk: evidence from a longitudinal study in China.

BMC geriatrics·2026
Same author

Antibody-drug conjugates in breast cancer: from mechanism to revolutionizing clinical practice.

Molecular cancer·2026
Same author

Spatially informed reference-free cell-type deconvolution for spatial transcriptomics with SpatialCD.

Genome research·2026
Same author

Food environment and cardiovascular kidney metabolic diseases mortality.

NPJ science of food·2026
Same author

Letter regarding "Survival outcomes and prognostic nomogram for primary pulmonary MALT lymphoma and diffuse large B-cell lymphoma: A SEER database study".

Biomolecules & biomedicine·2026
Same author

Correlation of thalamic functional organization disturbances and genetic architecture in motor subtypes of Parkinson's disease.

NPJ Parkinson's disease·2026
Same journal

Optimal transport for label transfer in single-cell multi-omics integration.

Briefings in bioinformatics·2026
Same journal

Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity.

Briefings in bioinformatics·2026
Same journal

Evaluating completeness, coherence, and consistency of genome-scale function annotations.

Briefings in bioinformatics·2026
Same journal

Transformers for single-cell RNA sequencing: a survey.

Briefings in bioinformatics·2026
Same journal

CLABP: a contrastive learning framework integrating protein language models and structural information for antibacterial peptide prediction.

Briefings in bioinformatics·2026
Same journal

Toward the regularization of E value from BLAST similarity search into a dissimilarity measure as distance function, and the metrication of protein sequence space.

Briefings in bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Multi-omics data integration for enhanced cancer subtyping via interactive multi-kernel learning.

Hongyan Cao1,2, Tong Wang1,3, Zhaoyang Xu1,3

  • 1Department of Health Statistics, Shanxi Provincial Key Laboratory of Major Diseases Risk Assessment, School of Public Health, Shanxi Medical University, No. 56 South Xinjian Road, Yingze District, Taiyuan, Shanxi 030001, PR China.

Briefings in Bioinformatics
|December 17, 2025
PubMed
Summary
This summary is machine-generated.

A new method, interactive multi-kernel learning (iMKL), identifies cancer subtypes by analyzing interactions between omics data. This approach improves accuracy in classifying renal cell carcinoma subtypes, revealing distinct survival differences and potential biomarkers.

Keywords:
interactive multi-kernel learningmulti-omics data integrationomics-omics interactionsubtype identificationunsupervised multi-kernel learning

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Related Experiment Videos

Last Updated: Jan 7, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Cancer is a complex, heterogeneous disease requiring advanced molecular analysis for effective treatment.
  • Multi-omics data integration is crucial for identifying subtypes and enabling personalized medicine.
  • Existing methods often fail to capture interactions between different omics data types.

Purpose of the Study:

  • To develop a novel method, interactive multi-kernel learning (iMKL), for improved cancer subtype identification.
  • To incorporate omics-omics interactions within an unsupervised multi-kernel learning framework.
  • To enhance the accuracy and robustness of cancer subtyping using multi-omics data.

Main Methods:

  • Developed iMKL, a method integrating omics-omics interactions and heterogeneous data types.
  • Utilized a joint Hadamard product strategy to capture higher-order interactive effects.
  • Applied iMKL to renal cell carcinoma (RCC) datasets (ccRCC and type II pRCC) with miRNA, mRNA, and DNA methylation data.

Main Results:

  • iMKL demonstrated strong robustness and accuracy in identifying patient subtypes via stability analysis.
  • Classified both ccRCC and type II pRCC into three distinct subtypes with significant survival differences.
  • Identified potential biomarkers associated with adverse patient outcomes.

Conclusions:

  • iMKL effectively identifies tumor molecular subtypes strongly associated with clinical features and survival.
  • The method offers substantial advancement in cancer subtyping and personalized treatment strategies.
  • iMKL provides valuable insights for clinical decision-making in oncology.